ARCHIVES

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

Program Project Guidelines Available

October 27, 1995

New Tenure Program Begins, NIH May Have 20-30 Positions Open

August 5, 1994

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

ASCO Survey Finds Practice Expenses 90% Higher Than Medicare Assumptions

October 11, 2002

Experts Say Interpretable Results Unlikely In Burzynski’s Antineoplastons Studies

September 25, 1998